Pulmonary Alveolar Microlithiasis: a Case Report in King Hussein Medical Center (KHMC), Amman, Jordan

Rakan M Haddad1, Jafar A Al-Momani1, Abdullah H Al-Omari2

  • 1Department of Internal Medicine, Respiratory Medicine Division, King Hussein Medical Center (KHMC), Amman, Jordan.

Abstract

Insights

Pulmonary Alveolar Microlithiasis (PAM) diagnosis is aided by chest CT and bone scintigraphy. Family screening is crucial, even for asymptomatic individuals, due to its hereditary nature.

Area of Science:

  • Pulmonary medicine
  • Radiology
  • Genetics

Background:

  • Pulmonary Alveolar Microlithiasis (PAM) is a rare, potentially hereditary lung disease.
  • Patients are often asymptomatic at diagnosis, presenting later with cough or dyspnea.
  • Early detection is challenging due to subtle initial symptoms.

Observation:

  • A 21-year-old male presented with abnormal chest X-ray findings.
  • High-resolution chest CT revealed diffuse bilateral microcalcifications.
  • Technetium-99m methylene diphosphonate (Tc-99m MDP) bone scintigraphy showed increased lung radiotracer uptake.

Findings:

  • Chest CT and bone scintigraphy confirmed Pulmonary Alveolar Microlithiasis.
  • The patient's asymptomatic father and sister were also diagnosed with PAM.
  • A familial pattern was evident, highlighting the hereditary aspect.

Implications:

  • Bone scintigraphy is vital for diagnosing PAM, avoiding invasive procedures.
  • Screening family members is essential, as over one-third of PAM cases have a familial link.
  • Early diagnosis through imaging facilitates timely management and genetic counseling.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...